Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

PX Wang, YX Ji, XJ Zhang, LP Zhao, ZZ Yan… - Nature medicine, 2017 - nature.com
Nonalcoholic steatohepatitis (NASH) is a progressive disease that is often accompanied by
metabolic syndrome and poses a high risk of severe liver damage. However, no effective …
被引用次数：221 相关文章

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

PX Wang, YX Ji, XJ Zhang, LP Zhao, ZZ Yan… - Nature Medicine, 2017 - go.gale.com
Nonalcoholic steatohepatitis (NASH) is a progressive disease that is often accompanied by
metabolic syndrome and poses a high risk of severe liver damage. However, no effective …

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

PX Wang, YX Ji, XJ Zhang, LP Zhao… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
Nonalcoholic steatohepatitis (NASH) is a progressive disease that is often accompanied by
metabolic syndrome and poses a high risk of severe liver damage. However, no effective …

[引用][C] Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

PX Wang, YX Ji, XJ Zhang, LP Zhao, ZZ Yan, P Zhang… - Nature Medicine, 2017 - cir.nii.ac.jp
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis
in mice and nonhuman primates | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

PX Wang, YX Ji, XJ Zhang, LP Zhao, ZZ Yan… - Nature …, 2017 - europepmc.org
A comment on this article appears in" AAV Immunogenicity: A Matter of Sensitivity." Mol Ther.
2018 Oct 3; 26 (10): 2335-2336. A comment on this article appears in" Impact of neutralizing …